Review



treatment bv2 mouse microglial cells  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 99

    Structured Review

    ATCC treatment bv2 mouse microglial cells
    Treatment Bv2 Mouse Microglial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 19080 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/treatment bv2 mouse microglial cells/product/ATCC
    Average 99 stars, based on 19080 article reviews
    treatment bv2 mouse microglial cells - by Bioz Stars, 2026-06
    99/100 stars

    Images



    Similar Products

    99
    ATCC treatment bv2 mouse microglial cells
    Treatment Bv2 Mouse Microglial Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/treatment bv2 mouse microglial cells/product/ATCC
    Average 99 stars, based on 1 article reviews
    treatment bv2 mouse microglial cells - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    86
    Procell Inc bv2 microglial cells
    Osteopontin may be the molecular bridge for Treg regulation of microglial function after ischemic stroke. (A) Immunoblotting analyses of OPN 21 days after intervention ( n = 4–5). (B) Experimental design for mRNA extraction from Treg cells. (C) mRNA expression of Spp1 in Treg cells. (D) Experimental design for <t>BV2</t> microglia in vitro . Created with Microsoft PowerPoint 2019. (E) Expression of inflammation-related genes. (F) More fluorescent microbeads (green) co-localized with microglia (Iba1 + ) (red; Alexa Fluor® 555). Scale bar: 50 μm. Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s honestly significant difference test). CM: Conditioned medium; DAPI: 4′,6-diamidino-2-phenylindole; Iba1: ionized calcium-binding adapter molecule 1; IL-10: interleukin 10; iNOS: inducible isoform of nitric oxide synthase; OGD/R: oxygen glucose deprivation/re-oxygenation; OPN: osteopontin; PE: physical exercise; qPCR: quantitative polymerase chain reaction; TGF-β: transforming growth factor-beta; tMCAO: transient middle cerebral artery occlusion; TNF-α: tumor necrosis factor-alpha; Treg cell: regulatory T cell.
    Bv2 Microglial Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bv2 microglial cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    bv2 microglial cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Servicebio Inc bv2 cells
    Melatonin suppresses NF-κB/NLRP3 inflammasome activation and microglial pyroptosis in the ischemic brain. (A) Representative western blotting images of NF-κB/NLRP3 inflammasome proteins in ischemic brain tissues and sham controls treated with MLT or vehicle at 72 hours after reperfusion after MCAO. (B) Quantification of the western blotting data. n = 6 per group. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Chromatin immunoprecipitation (ChIP) assay of NF-κB and GSDMD in <t>BV2</t> cells treated with lipopolysaccharide. n = 3 per group. The JASPAR website predicted the existence of a binding site between NF-κB and the GSDMD promoter region ( Additional Figure 1 ). Data are presented as mean ± SD. ** P < 0.01 (Student’s t -test). (D) Double immunostaining for Iba-1 (green) and GSDMD (red) at 72 hours after MCAO in the peri-ischemic area as well as in the corresponding regions of sham control brains, both of which were treated with MLT or vehicle. Nuclei were stained with DAPI (blue). Scale bar: 20 μm (10 μm in the magnified images). Arrowheads indicate GSDMD-double-positive cells with microglia-specific markers. All experiments were conducted in triplicate. cGAS: Cyclic GMP-AMP synthase; DAPI: 4′,6-diamidino-2-phenylindole; GSDMD: gasdermin D; Iba-1: ionized calcium-binding adapter molecule 1; IL: interleukin; MCAO: middle cerebral artery occlusion; MLT: melatonin; NF-κB: nuclear factor kappa-B; NLRP3: NOD-like receptor family pyrin domain-containing protein 3; ns: not significant.
    Bv2 Cells, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bv2 cells/product/Servicebio Inc
    Average 86 stars, based on 1 article reviews
    bv2 cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Korean Cell Line Bank bv2 cells
    Melatonin suppresses NF-κB/NLRP3 inflammasome activation and microglial pyroptosis in the ischemic brain. (A) Representative western blotting images of NF-κB/NLRP3 inflammasome proteins in ischemic brain tissues and sham controls treated with MLT or vehicle at 72 hours after reperfusion after MCAO. (B) Quantification of the western blotting data. n = 6 per group. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Chromatin immunoprecipitation (ChIP) assay of NF-κB and GSDMD in <t>BV2</t> cells treated with lipopolysaccharide. n = 3 per group. The JASPAR website predicted the existence of a binding site between NF-κB and the GSDMD promoter region ( Additional Figure 1 ). Data are presented as mean ± SD. ** P < 0.01 (Student’s t -test). (D) Double immunostaining for Iba-1 (green) and GSDMD (red) at 72 hours after MCAO in the peri-ischemic area as well as in the corresponding regions of sham control brains, both of which were treated with MLT or vehicle. Nuclei were stained with DAPI (blue). Scale bar: 20 μm (10 μm in the magnified images). Arrowheads indicate GSDMD-double-positive cells with microglia-specific markers. All experiments were conducted in triplicate. cGAS: Cyclic GMP-AMP synthase; DAPI: 4′,6-diamidino-2-phenylindole; GSDMD: gasdermin D; Iba-1: ionized calcium-binding adapter molecule 1; IL: interleukin; MCAO: middle cerebral artery occlusion; MLT: melatonin; NF-κB: nuclear factor kappa-B; NLRP3: NOD-like receptor family pyrin domain-containing protein 3; ns: not significant.
    Bv2 Cells, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bv2 cells/product/Korean Cell Line Bank
    Average 86 stars, based on 1 article reviews
    bv2 cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc bv2 microglia cells
    Melatonin suppresses NF-κB/NLRP3 inflammasome activation and microglial pyroptosis in the ischemic brain. (A) Representative western blotting images of NF-κB/NLRP3 inflammasome proteins in ischemic brain tissues and sham controls treated with MLT or vehicle at 72 hours after reperfusion after MCAO. (B) Quantification of the western blotting data. n = 6 per group. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Chromatin immunoprecipitation (ChIP) assay of NF-κB and GSDMD in <t>BV2</t> cells treated with lipopolysaccharide. n = 3 per group. The JASPAR website predicted the existence of a binding site between NF-κB and the GSDMD promoter region ( Additional Figure 1 ). Data are presented as mean ± SD. ** P < 0.01 (Student’s t -test). (D) Double immunostaining for Iba-1 (green) and GSDMD (red) at 72 hours after MCAO in the peri-ischemic area as well as in the corresponding regions of sham control brains, both of which were treated with MLT or vehicle. Nuclei were stained with DAPI (blue). Scale bar: 20 μm (10 μm in the magnified images). Arrowheads indicate GSDMD-double-positive cells with microglia-specific markers. All experiments were conducted in triplicate. cGAS: Cyclic GMP-AMP synthase; DAPI: 4′,6-diamidino-2-phenylindole; GSDMD: gasdermin D; Iba-1: ionized calcium-binding adapter molecule 1; IL: interleukin; MCAO: middle cerebral artery occlusion; MLT: melatonin; NF-κB: nuclear factor kappa-B; NLRP3: NOD-like receptor family pyrin domain-containing protein 3; ns: not significant.
    Bv2 Microglia Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bv2 microglia cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    bv2 microglia cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc murine microglial cell line bv2
    Propranolol reduced the expression of NLRP3 and IL-1β in <t>BV2</t> cells subjected to OGD/R (A) Schematic of cell experiment steps. (B) Western blot analysis of NLRP3 and IL-1β in BV2 cells at 4, 6, 8, 12, and 24 h after OGD/R. (C and D) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the control group. (E) Western blot analysis of NLRP3 and IL-1β in BV2 cells of different treatment groups. (F and G) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.
    Murine Microglial Cell Line Bv2, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine microglial cell line bv2/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    murine microglial cell line bv2 - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    86
    Procell Inc mouse bv2 microglial cells
    Propranolol reduced the expression of NLRP3 and IL-1β in <t>BV2</t> cells subjected to OGD/R (A) Schematic of cell experiment steps. (B) Western blot analysis of NLRP3 and IL-1β in BV2 cells at 4, 6, 8, 12, and 24 h after OGD/R. (C and D) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the control group. (E) Western blot analysis of NLRP3 and IL-1β in BV2 cells of different treatment groups. (F and G) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.
    Mouse Bv2 Microglial Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse bv2 microglial cells/product/Procell Inc
    Average 86 stars, based on 1 article reviews
    mouse bv2 microglial cells - by Bioz Stars, 2026-06
    86/100 stars
      Buy from Supplier

    95
    ATCC bv2 cell line
    (A-C) Representative confocal images showing fluorescence signals of GSDMD + (red, A-C), NLRP3 + (red, D-F) and Caspase1 + (red, G-I) in control and EcoHIV infected <t>BV2</t> microglia cells w or w/o MCC950 treatment. The green fluorescence signals of eGFP signify the EcoHIV-infected microglia in BV2 cell line in vitro . The dual-labeling of EcoHIV + /GSDMD + (C), EcoHIV + /NLRP3 + (F) and EcoHIV + /Caspase1 + (I) show the colocalization of targeted proteins in EcoHIV-infected cells. (J-L) Quantification of integrative density of HLA-DR (J), PD-1 (K) and Ki67 (L) expression in immunofluorescence-stained EcoHIV + cells, classified by HIV and MCC950 status. Data are presented as mean ± SEM; p-values determined by t -test are indicated. Scale bar, 50 µm.
    Bv2 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bv2 cell line/product/ATCC
    Average 95 stars, based on 1 article reviews
    bv2 cell line - by Bioz Stars, 2026-06
    95/100 stars
      Buy from Supplier

    Image Search Results


    Osteopontin may be the molecular bridge for Treg regulation of microglial function after ischemic stroke. (A) Immunoblotting analyses of OPN 21 days after intervention ( n = 4–5). (B) Experimental design for mRNA extraction from Treg cells. (C) mRNA expression of Spp1 in Treg cells. (D) Experimental design for BV2 microglia in vitro . Created with Microsoft PowerPoint 2019. (E) Expression of inflammation-related genes. (F) More fluorescent microbeads (green) co-localized with microglia (Iba1 + ) (red; Alexa Fluor® 555). Scale bar: 50 μm. Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s honestly significant difference test). CM: Conditioned medium; DAPI: 4′,6-diamidino-2-phenylindole; Iba1: ionized calcium-binding adapter molecule 1; IL-10: interleukin 10; iNOS: inducible isoform of nitric oxide synthase; OGD/R: oxygen glucose deprivation/re-oxygenation; OPN: osteopontin; PE: physical exercise; qPCR: quantitative polymerase chain reaction; TGF-β: transforming growth factor-beta; tMCAO: transient middle cerebral artery occlusion; TNF-α: tumor necrosis factor-alpha; Treg cell: regulatory T cell.

    Journal: Neural Regeneration Research

    Article Title: Physical exercise promotes white matter repair after ischemic stroke

    doi: 10.4103/NRR.NRR-D-24-00861

    Figure Lengend Snippet: Osteopontin may be the molecular bridge for Treg regulation of microglial function after ischemic stroke. (A) Immunoblotting analyses of OPN 21 days after intervention ( n = 4–5). (B) Experimental design for mRNA extraction from Treg cells. (C) mRNA expression of Spp1 in Treg cells. (D) Experimental design for BV2 microglia in vitro . Created with Microsoft PowerPoint 2019. (E) Expression of inflammation-related genes. (F) More fluorescent microbeads (green) co-localized with microglia (Iba1 + ) (red; Alexa Fluor® 555). Scale bar: 50 μm. Data are expressed as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s honestly significant difference test). CM: Conditioned medium; DAPI: 4′,6-diamidino-2-phenylindole; Iba1: ionized calcium-binding adapter molecule 1; IL-10: interleukin 10; iNOS: inducible isoform of nitric oxide synthase; OGD/R: oxygen glucose deprivation/re-oxygenation; OPN: osteopontin; PE: physical exercise; qPCR: quantitative polymerase chain reaction; TGF-β: transforming growth factor-beta; tMCAO: transient middle cerebral artery occlusion; TNF-α: tumor necrosis factor-alpha; Treg cell: regulatory T cell.

    Article Snippet: BV2 microglial cells (Procell, Wuhan, China, CL0493, RRID: CVCL_0182) and MO3.13 oligodendrocyte cells (EK-Bioscience, shanghai, China, CC-Y1772, RRID: CVCL_D357) were cultured in Dulbecco’s modified Eagle medium (Gibco) containing 10% fetal bovine serum (ScienCell) at 37°C in a 5% CO 2 incubator.

    Techniques: Western Blot, Extraction, Expressing, In Vitro, Binding Assay, Real-time Polymerase Chain Reaction

    Melatonin suppresses NF-κB/NLRP3 inflammasome activation and microglial pyroptosis in the ischemic brain. (A) Representative western blotting images of NF-κB/NLRP3 inflammasome proteins in ischemic brain tissues and sham controls treated with MLT or vehicle at 72 hours after reperfusion after MCAO. (B) Quantification of the western blotting data. n = 6 per group. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Chromatin immunoprecipitation (ChIP) assay of NF-κB and GSDMD in BV2 cells treated with lipopolysaccharide. n = 3 per group. The JASPAR website predicted the existence of a binding site between NF-κB and the GSDMD promoter region ( Additional Figure 1 ). Data are presented as mean ± SD. ** P < 0.01 (Student’s t -test). (D) Double immunostaining for Iba-1 (green) and GSDMD (red) at 72 hours after MCAO in the peri-ischemic area as well as in the corresponding regions of sham control brains, both of which were treated with MLT or vehicle. Nuclei were stained with DAPI (blue). Scale bar: 20 μm (10 μm in the magnified images). Arrowheads indicate GSDMD-double-positive cells with microglia-specific markers. All experiments were conducted in triplicate. cGAS: Cyclic GMP-AMP synthase; DAPI: 4′,6-diamidino-2-phenylindole; GSDMD: gasdermin D; Iba-1: ionized calcium-binding adapter molecule 1; IL: interleukin; MCAO: middle cerebral artery occlusion; MLT: melatonin; NF-κB: nuclear factor kappa-B; NLRP3: NOD-like receptor family pyrin domain-containing protein 3; ns: not significant.

    Journal: Neural Regeneration Research

    Article Title: Melatonin alleviates neuroinflammation in ischemic stroke by regulating cyclic GMP-AMP synthase– mediated microglial pyroptosis signaling

    doi: 10.4103/NRR.NRR-D-24-01070

    Figure Lengend Snippet: Melatonin suppresses NF-κB/NLRP3 inflammasome activation and microglial pyroptosis in the ischemic brain. (A) Representative western blotting images of NF-κB/NLRP3 inflammasome proteins in ischemic brain tissues and sham controls treated with MLT or vehicle at 72 hours after reperfusion after MCAO. (B) Quantification of the western blotting data. n = 6 per group. Data are presented as mean ± SD. * P < 0.05, ** P < 0.01, *** P < 0.001 (one-way analysis of variance followed by Tukey’s post hoc test). (C) Chromatin immunoprecipitation (ChIP) assay of NF-κB and GSDMD in BV2 cells treated with lipopolysaccharide. n = 3 per group. The JASPAR website predicted the existence of a binding site between NF-κB and the GSDMD promoter region ( Additional Figure 1 ). Data are presented as mean ± SD. ** P < 0.01 (Student’s t -test). (D) Double immunostaining for Iba-1 (green) and GSDMD (red) at 72 hours after MCAO in the peri-ischemic area as well as in the corresponding regions of sham control brains, both of which were treated with MLT or vehicle. Nuclei were stained with DAPI (blue). Scale bar: 20 μm (10 μm in the magnified images). Arrowheads indicate GSDMD-double-positive cells with microglia-specific markers. All experiments were conducted in triplicate. cGAS: Cyclic GMP-AMP synthase; DAPI: 4′,6-diamidino-2-phenylindole; GSDMD: gasdermin D; Iba-1: ionized calcium-binding adapter molecule 1; IL: interleukin; MCAO: middle cerebral artery occlusion; MLT: melatonin; NF-κB: nuclear factor kappa-B; NLRP3: NOD-like receptor family pyrin domain-containing protein 3; ns: not significant.

    Article Snippet: BV2 cells were obtained from Servicebio (Wuhan, Hubei, China; Cat# STCC20009G-1) and cultivated in Dulbecco’s modified Eagle’s medium (DMEM; Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; Gibco), and 100 U/mL penicillin and 100 mg/mL streptomycin (Gibco) at 37°C in a humidified cell incubator.

    Techniques: Activation Assay, Western Blot, Chromatin Immunoprecipitation, Binding Assay, Double Immunostaining, Control, Staining

    Propranolol reduced the expression of NLRP3 and IL-1β in BV2 cells subjected to OGD/R (A) Schematic of cell experiment steps. (B) Western blot analysis of NLRP3 and IL-1β in BV2 cells at 4, 6, 8, 12, and 24 h after OGD/R. (C and D) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the control group. (E) Western blot analysis of NLRP3 and IL-1β in BV2 cells of different treatment groups. (F and G) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.

    Journal: iScience

    Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway

    doi: 10.1016/j.isci.2026.115779

    Figure Lengend Snippet: Propranolol reduced the expression of NLRP3 and IL-1β in BV2 cells subjected to OGD/R (A) Schematic of cell experiment steps. (B) Western blot analysis of NLRP3 and IL-1β in BV2 cells at 4, 6, 8, 12, and 24 h after OGD/R. (C and D) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, and ∗∗∗∗ p < 0.0001 versus the control group. (E) Western blot analysis of NLRP3 and IL-1β in BV2 cells of different treatment groups. (F and G) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.

    Article Snippet: The murine microglial cell line BV2 was obtained from Procell Life Science & Technology Co., Ltd. (Procell, Cat# CL-0493).

    Techniques: Expressing, Western Blot, Control

    Blockade of β2-AR reduced the expression of NLRP3 in BV2 cells subjected to OGD/R (A) Western blot analysis of the effects of dobutamine and betaxolol on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the control group. (D) Western blot analysis of salmeterol and ICI118,551 on NLRP3 and IL-1β expression in BV2 cells. (E and F) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.

    Journal: iScience

    Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway

    doi: 10.1016/j.isci.2026.115779

    Figure Lengend Snippet: Blockade of β2-AR reduced the expression of NLRP3 in BV2 cells subjected to OGD/R (A) Western blot analysis of the effects of dobutamine and betaxolol on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗∗ p < 0.001 versus the control group. (D) Western blot analysis of salmeterol and ICI118,551 on NLRP3 and IL-1β expression in BV2 cells. (E and F) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗ p < 0.05, ∗∗ p < 0.01, and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 and ## p < 0.01 versus the OGD/R group.

    Article Snippet: The murine microglial cell line BV2 was obtained from Procell Life Science & Technology Co., Ltd. (Procell, Cat# CL-0493).

    Techniques: Expressing, Western Blot, Control

    Activation of β2-AR induced the expression of NLRP3 and IL-1β via the ERK1/2 MAPK signaling pathway (A) Western blot analysis of the effects of H-89 and U0126 on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group. (D) Western blot analysis of p -ERK1/2 expression in BV2 cells. (E) Quantitative analysis of p -ERK1/2 expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group.

    Journal: iScience

    Article Title: Propranolol alleviates cerebral infarction through the β2-AR-mediated ERK/NLRP3 pathway

    doi: 10.1016/j.isci.2026.115779

    Figure Lengend Snippet: Activation of β2-AR induced the expression of NLRP3 and IL-1β via the ERK1/2 MAPK signaling pathway (A) Western blot analysis of the effects of H-89 and U0126 on NLRP3 and IL-1β expression in BV2 cells. (B and C) Quantitative analysis of NLRP3 and IL-1β expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group. (D) Western blot analysis of p -ERK1/2 expression in BV2 cells. (E) Quantitative analysis of p -ERK1/2 expression ( n = 3 biological replicates per group, each with 3 technical replicates). Data were expressed as mean ± SD. Statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc test. ∗∗ p < 0.01 and ∗∗∗ p < 0.001 versus the control group; # p < 0.05 versus the OGD/R group.

    Article Snippet: The murine microglial cell line BV2 was obtained from Procell Life Science & Technology Co., Ltd. (Procell, Cat# CL-0493).

    Techniques: Activation Assay, Expressing, Western Blot, Control

    (A-C) Representative confocal images showing fluorescence signals of GSDMD + (red, A-C), NLRP3 + (red, D-F) and Caspase1 + (red, G-I) in control and EcoHIV infected BV2 microglia cells w or w/o MCC950 treatment. The green fluorescence signals of eGFP signify the EcoHIV-infected microglia in BV2 cell line in vitro . The dual-labeling of EcoHIV + /GSDMD + (C), EcoHIV + /NLRP3 + (F) and EcoHIV + /Caspase1 + (I) show the colocalization of targeted proteins in EcoHIV-infected cells. (J-L) Quantification of integrative density of HLA-DR (J), PD-1 (K) and Ki67 (L) expression in immunofluorescence-stained EcoHIV + cells, classified by HIV and MCC950 status. Data are presented as mean ± SEM; p-values determined by t -test are indicated. Scale bar, 50 µm.

    Journal: bioRxiv

    Article Title: NLRP3 inflammasome-related microglial pyroptosis in EcoHIV infected mice

    doi: 10.64898/2026.04.29.721781

    Figure Lengend Snippet: (A-C) Representative confocal images showing fluorescence signals of GSDMD + (red, A-C), NLRP3 + (red, D-F) and Caspase1 + (red, G-I) in control and EcoHIV infected BV2 microglia cells w or w/o MCC950 treatment. The green fluorescence signals of eGFP signify the EcoHIV-infected microglia in BV2 cell line in vitro . The dual-labeling of EcoHIV + /GSDMD + (C), EcoHIV + /NLRP3 + (F) and EcoHIV + /Caspase1 + (I) show the colocalization of targeted proteins in EcoHIV-infected cells. (J-L) Quantification of integrative density of HLA-DR (J), PD-1 (K) and Ki67 (L) expression in immunofluorescence-stained EcoHIV + cells, classified by HIV and MCC950 status. Data are presented as mean ± SEM; p-values determined by t -test are indicated. Scale bar, 50 µm.

    Article Snippet: BV2 cell line was purchased from ATCC (Cat. No. CRL-2469, ATCC) and cultured in DMEM/F12 growth medium with 10% fetal serum at 37°C, 5% CO condition.

    Techniques: Fluorescence, Control, Infection, In Vitro, Labeling, Expressing, Immunofluorescence, Staining

    (A-C) Representative confocal images showing fluorescence signals of HLA-DR + (red, A-C), PD-1 + (red, D-F) and Ki67 + (red, G-I) in control and EcoHIV-infected BV2 microglia cells with or without MCC950 treatment. The green fluorescence signals of eGFP stand for the EcoHIV-infected microglia in BV2 cell line in vitro . The dual-labeling of EcoHIV + /HLA-DR + (C), EcoHIV + /PD-1 + (F) and EcoHIV + /KI67 + (I) show the colocalization of targeted proteins in EcoHIV-infected cells. (J-L) Quantification of integrative density of HLA-DR (J), PD-1 (K) and Ki67 (L) expression in immunofluorescence-stained EcoHIV + cells, classified by HIV and MCC950 status. Data are presented as mean ± SEM; p-values determined by t -test are indicated. Scale bar, 50 µm.

    Journal: bioRxiv

    Article Title: NLRP3 inflammasome-related microglial pyroptosis in EcoHIV infected mice

    doi: 10.64898/2026.04.29.721781

    Figure Lengend Snippet: (A-C) Representative confocal images showing fluorescence signals of HLA-DR + (red, A-C), PD-1 + (red, D-F) and Ki67 + (red, G-I) in control and EcoHIV-infected BV2 microglia cells with or without MCC950 treatment. The green fluorescence signals of eGFP stand for the EcoHIV-infected microglia in BV2 cell line in vitro . The dual-labeling of EcoHIV + /HLA-DR + (C), EcoHIV + /PD-1 + (F) and EcoHIV + /KI67 + (I) show the colocalization of targeted proteins in EcoHIV-infected cells. (J-L) Quantification of integrative density of HLA-DR (J), PD-1 (K) and Ki67 (L) expression in immunofluorescence-stained EcoHIV + cells, classified by HIV and MCC950 status. Data are presented as mean ± SEM; p-values determined by t -test are indicated. Scale bar, 50 µm.

    Article Snippet: BV2 cell line was purchased from ATCC (Cat. No. CRL-2469, ATCC) and cultured in DMEM/F12 growth medium with 10% fetal serum at 37°C, 5% CO condition.

    Techniques: Fluorescence, Control, Infection, In Vitro, Labeling, Expressing, Immunofluorescence, Staining